Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study (Bone Marrow Transplantation, (2021), 56, 3, (692-695), 10.1038/s41409-020-01013-y)

Johannes Schetelig*, Jennifer Hoek, Stephan Stilgenbauer, Jan Moritz Middeke, Niels Smedegaard Andersen, Christopher P. Fox, Stig Lenhoff, Liisa Volin, Avichai Shimoni, Wilfried Schroyens, Michel van Gelder, Donald Bunjes, Anja van Biezen, Henning Baldauf, Liesbeth C. de Wreede, Olivier Tournilhac, Nicolaus Kröger, Ibrahim Yakoub-Agha, Peter Dreger

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study, written by Johannes Schetelig JJennifer Hoek, Stephan Stilgenbauer, Jan Moritz Middeke, Niels Smedegaard Andersen,Christopher P. Fox, Stig Lenhoff, Liisa Volin, Avichai Shimoni, Wilfried Schroyens, Michel van Gelder, Donald Bunjes, Anja van Biezen, Henning Baldauf, Liesbeth C. de Wreede, Olivier Tournilhac, Nicolaus Kröger, Ibrahim Yakoub-Agha, Peter Dreger was originally published Online First without Open Access. After publication in volume 56, issue 3, page 692-695 the author decided to opt for Open Choice and to make the article an Open Access publication.

Original languageEnglish
Pages (from-to)144
Number of pages1
JournalBone Marrow Transplantation
Volume57
Issue number1
DOIs
StatePublished - Jan 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study (Bone Marrow Transplantation, (2021), 56, 3, (692-695), 10.1038/s41409-020-01013-y)'. Together they form a unique fingerprint.

Cite this